He hopes to develop a vaccine that is effective against all types of coronavirus and their variants. Lbachir BenMohamed, Moroccan immunologist at the head of a cellular and molecular immunology laboratory affiliated with the prestigious University of California, Irvine, is currently testing fifteen candidate vaccines developed by his team on mice. “We hope to move on to clinical trials at the end of 2021 or at the beginning of 2022 at the latest,” he said at the microphone of Europe 1.
For this researcher, the development of a “universal” vaccine will not only make it possible to fight the pandemic which has struck the whole world for more than a year, but to anticipate other health crises linked to the coronavirus family. The question is not whether it will happen, but when it will happen, ”he explains.